# The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024, Regulation 57: Amendment to regulation 71

Extent: E+W+S+N.I.

In regulation 71(1), for sub-paragraph (b) (withdrawal of medicinal product from the market) substitute—
“(b) under regulation 69 the licensing authority suspends the use, sale, supply or offer for sale or supply within the United Kingdom of a product to which a UK marketing authorisation relates.”.

---
Source: https://www.legislation.gov.uk/uksi/2024/832/regulation/57 (the official version)
Page: https://openlegislation.uk/human-medicines-amendments-relating-to-the-windsor-framework-regulations-2024/regulation-57
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.